Literature DB >> 7025878

Immunohistochemical demonstration of amyloid P component in skin of normal subjects and patients with cutaneous amyloidosis.

S M Breathnach, B Bhogal, R F Dyck, F C De Beer, M M Black, M B Pepys.   

Abstract

The presence of amyloid P component (AP) in dermal deposits of cutaneous amyloidosis was demonstrated by a direct immunofluorescence technique using an antibody to serum amyloid P component (SAP). AP was also shown, for the first time, to be a constituent of normal human skin. It was present at the periphery of dermal elastic tissue fibres, in basement membranes of dermal blood vessels and surrounding eccrine sweat glands but was absent from the dermo-epidermal basement membrane. The staining pattern in cutaneous amyloidosis was morphologically distinctive and readily distinguishable from staining of thickened vascular basement membranes in porphyria. Immunofluorescence with anti-SAP is simple and specific and may become the procedure of choice in the differential diagnosis of amyloidosis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7025878     DOI: 10.1111/j.1365-2133.1981.tb01195.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  Fluorescence microscopical visualization of elastic fibres using basic fuchsin.

Authors:  K Pihlman; E Linder
Journal:  Histochemistry       Date:  1983

2.  Skin deposits in hereditary cystatin C amyloidosis.

Authors:  E Benedikz; H Blöndal; G Gudmundsson
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

3.  In vitro amyloidogenic peptides of galectin-7: possible mechanism of amyloidogenesis of primary localized cutaneous amyloidosis.

Authors:  Koji Ono; Eita Fujimoto; Norihiro Fujimoto; Minoru Akiyama; Takahiro Satoh; Hiroki Maeda; Noriko Fujii; Shingo Tajima
Journal:  J Biol Chem       Date:  2014-08-29       Impact factor: 5.157

4.  Immunohistochemical characterization of amyloid proteins in sural nerves and clinical associations in amyloid neuropathy.

Authors:  K Li; R A Kyle; P J Dyck
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

Review 5.  Microvascular pathology and vascular basement membrane components in Alzheimer's disease.

Authors:  L S Perlmutter
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

6.  Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study.

Authors:  Ashutosh Wechalekar; Gunnar Antoni; Wasfi Al Azzam; Mats Bergström; Swethajit Biswas; Chao Chen; Joseph Cheriyan; Matthew Cleveland; Louise Cookson; Paul Galette; Robert L Janiczek; Raymond Y Kwong; Mary Ann Lukas; Helen Millns; Duncan Richards; Ian Schneider; Scott D Solomon; Jens Sörensen; James Storey; Douglas Thompson; Guus van Dongen; Danielle J Vugts; Anders Wall; Gerhard Wikström; Rodney H Falk
Journal:  BMC Cardiovasc Disord       Date:  2022-02-13       Impact factor: 2.298

Review 7.  Targeting Amyloid Fibrils by Passive Immunotherapy in Systemic Amyloidosis.

Authors:  Mario Nuvolone; Alice Nevone; Giampaolo Merlini
Journal:  BioDrugs       Date:  2022-09-12       Impact factor: 7.744

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.